JeffreyLeeCummingsMDScD

Dementia & Geriatrics

Director, Cleveland Clinic Lou Ruvo Center for Brain Health; Camille and Larry Ruvo Chair for Brain Health; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Join to view full profile

Dr. Cummings is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cummings' full profile

Already have an account?

Office
300 Medical Plz
# B200
Los Angeles, CA 90095
Phone+1 310-825-6183

Fax+1 702-483-6028

Education & Training

Boston University Medical CenterResidency, Neurology, 1977 - 1979
Boston University Medical CenterResidency, Neurology, 1975 - 1977
Hartford HospitalInternship, Transitional Year, 1974 - 1975
University of Washington School of MedicineClass of 1974

Certifications & Licensure

CA State Medical License 1980 - 2026
NV State Medical License 2011 - 2025
OH State Medical License 2011 - 2017
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Vegas Seven Castle Connolly, 2014
America's Top Doctors Castle Connolly, 2002-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease Start of enrollment: 2010 Oct 01
Completed
Phase 4
Bexarotene Amyloid Treatment for Alzheimer's Disease Start of enrollment: 2013 Feb 01
Completed
Phase 2
TRC-PAD Program: In-Clinic Trial-Ready Cohort Start of enrollment: 2019 Jun 04
Active, not recruiting

Publications & Presentations

PubMed

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-st...
Jeffrey L Cummings, Alireza Atri, Howard H Feldman, Oskar Hansson, Mary Sano
Alzheimer's Research & Therapy. 2025-01-08
A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease.
Kate Zhong, Jeffrey Cummings
Expert Review of Neurotherapeutics. 2025-01-01
Appropriate use of meaningful within-patient change (MWPC) thresholds in Alzheimer's disease.
Claire J Lansdall, Jeffrey L Cummings, Jeffrey Scott Andrews
Alzheimer's & Dementia. 2024-12-18

Lectures

American Neuropsychiatric Association (ANPA): 24th Annual Meeting
American Neuropsychiatric Association, Boston, Massachusetts - 4/3/2013
2012 Neurology Update – A Comprehensive Board Review for the Clinician Featuring Self-Assessment Examination
Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Washington, Dist Of Col - 8/3/2012

Press Mentions

Network-Based Analyses Uncover How Harmful Microglia Form in Alzheimer’s DiseaseDecember 10th, 2024
Alzheimer's Progression May Be Slowed by Targeted Magnetic Pulses, Study SuggestsNovember 3rd, 2024
Personalized Neuromodulation Treatment Significantly Slowed Alzheimer’s Progression in 12-Month Phase 2 Study, Meeting Primary and Key Secondary EndpointsOctober 31st, 2024
Join now to see all

Grant Support

Administrative CoreNational Institute On Aging2004–2012
UCLA Alzheimers Disease Research CenterNational Center For Research Resources2004–2011
UCLA Alzheimer'S Disease Research CenterNational Institute On Aging2004–2009
UCLA Alzheimer'S Disease Center DatabaseNational Center For Research Resources2005–2008
Genetic Risk Factors As Determinants Of The Outcome Of Clinical Trials In AlzNational Center For Research Resources2005–2008
Dementia And Disability In Thai ElderlyNational Center For Research Resources2005–2008
A Randomized, Double-Blind, Placebo-Controlled Trial Of Valproate To AttenuatNational Center For Research Resources2005–2008
Multicenter Analysis Of Hippocampal Morphology In MCINational Center For Research Resources2004–2008
Assessment Measures For Alzheimer'S Disease Primary Prevention TrialsNational Center For Research Resources2004–2007
A Randomized, Double-Blind, Placebo-Controlled Trial Of Vitamin E And AriceptNational Center For Research Resources2005
Dementia And Disability In Thai ElderlyFogarty International Center2003–2005
Trial Of Vitamin E And AriceptNational Center For Research Resources2004
Treatment Of Agitation/Psychosis In Dementia/ParkinsonisNational Center For Research Resources2004
Neuropathologic Diagnosis In Alzheimer'S DiseaseNational Center For Research Resources2004
Effects Of Testosterone/Placebo In Males W/Alzheimer'SNational Center For Research Resources2004
-K...National Center For Research Resources2004
UCLA Alzheimers Disease Research CenterNational Institute On Aging1999–2003
Dementia And Behavioral Neurology: Research FellowshipNational Institute On Aging1998–2003
In Vivo Correlates Of Neuropathologic Diagnosis In Alzheimers DiseaseNational Center For Research Resources1998–2002
Trial Of VIT E/Aricept--Cognition Disorder Therapy In ADNational Center For Research Resources2001
Phase II Trial Of Donepezil In PTS With CVD DementiaNational Center For Research Resources2001
Sertraline In Treatment Of Behaviors In Alzheimers PatientsNational Center For Research Resources1999–2001
Multicenter, Placebo Controlled Trial Of Melatonin For Sleep DisturbanceNational Center For Research Resources1999–2001
Metrifonate: Effects On Brain Function, Brain Metabolism, &BehaviorNational Center For Research Resources1999–2001
Efficacy Of The Xanomeline Transdermal Therapeutic System In Alzheimer'S DiseaseNational Center For Research Resources1998–2001
Alzheimers Disease CenterNational Institute On Aging1994–1998
UCLA Alzheimers Disease CenterNational Institute On Aging1991–1998
LOS Angeles Area Alzheimer'S Outreach Program (LAAAOP)National Institute On Aging1995–1997
Dementia And Behavioral Neurology: Research FellowshipNational Institute On Aging1995–1997
Measurement And Prognostic Value Of Eps--Effects Of NeurolepticsNational Institute Of Mental Health1995
LOS Angeles Area Alzheimers Outreach ProjectNational Institute On Aging1994
LOS Angeles Area Alzheimer'S Outreach ProjectNational Institute On Aging1992–1993